15,171 Shares in Beyond Air, Inc. (NASDAQ:XAIR) Bought by Keel Point LLC

Keel Point LLC bought a new position in shares of Beyond Air, Inc. (NASDAQ:XAIR) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 15,171 shares of the company’s stock, valued at approximately $30,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of XAIR. BlackRock Inc. boosted its position in shares of Beyond Air by 497.6% during the 2nd quarter. BlackRock Inc. now owns 1,728,410 shares of the company’s stock worth $7,363,000 after acquiring an additional 1,439,168 shares in the last quarter. State Street Corp boosted its position in shares of Beyond Air by 259.5% during the 2nd quarter. State Street Corp now owns 368,154 shares of the company’s stock worth $1,568,000 after acquiring an additional 265,747 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Beyond Air by 93.1% during the 2nd quarter. Geode Capital Management LLC now owns 501,409 shares of the company’s stock worth $2,136,000 after acquiring an additional 241,688 shares in the last quarter. Gendell Jeffrey L boosted its position in shares of Beyond Air by 26.3% during the 3rd quarter. Gendell Jeffrey L now owns 1,090,297 shares of the company’s stock worth $2,519,000 after acquiring an additional 226,959 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Beyond Air by 202.3% during the 2nd quarter. Northern Trust Corp now owns 250,245 shares of the company’s stock worth $1,066,000 after acquiring an additional 167,458 shares in the last quarter. 31.50% of the stock is owned by institutional investors and hedge funds.

Beyond Air Stock Down 3.8 %

Beyond Air stock opened at $1.28 on Thursday. Beyond Air, Inc. has a fifty-two week low of $1.17 and a fifty-two week high of $6.36. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.26 and a current ratio of 3.39. The company has a market capitalization of $46.13 million, a P/E ratio of -0.60 and a beta of -0.18. The stock has a 50-day simple moving average of $1.72 and a 200-day simple moving average of $1.81.

Beyond Air (NASDAQ:XAIR) last posted its earnings results on Monday, February 12th. The company reported ($0.50) earnings per share for the quarter, beating the consensus estimate of ($0.61) by $0.11. The firm had revenue of $0.39 million during the quarter, compared to analysts’ expectations of $0.49 million. During the same period in the previous year, the firm posted ($0.43) earnings per share. Equities research analysts expect that Beyond Air, Inc. will post -1.93 earnings per share for the current year.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.